Lab & Allied invests Kshs 1billion towards the launch of new medicines

Laboratory & Allied, a local pharmaceutical manufacturing company recently launched four new medicines in the East African market to help towards alleviating various conditions.

The pharmaceutical company, has invested Kshs1 billion towards the development and launch of the four new medicines as the company celebrates 45 years since inception.

Commenting during the launch, Mr. Suprakash Mandal, Chief Executive Officer, Laboratory & Allied said that as part of its 45 years celebration in the East African market, the company has launched the four new medicines in Kenya, Tanzania and Ethiopia.

“As a company, we have invested Kshs 1 billion shillings towards the launch of these four new medicines. Out of these, 30% has been directed towards increasing production capacity, an additional 30% towards packaging and 40% towards registration of the products in the respective countries,” said Mandal.

The new medicines are Diagone Kit, for the management of diarrhoea in children under the age of five years, Heligone – a three drug combination for the treatment of H-Pylori infections.

The other drugs are Gynagone, a three drug combination for treatment of gynecological infections and Sucra – an artificial sweetener for diabetics and calorie conscious people.

The launch of the four new medicines is part of the expansion strategy in the East African market the pharmaceutical company announced in April this year.

Lab & Allied Ltd is a fast growing pharmaceutical and manufacturing company dealing in the production of both human and veterinary products and committed to building a next generation of generics drugs locally and regionally.


Leave a Reply

Your email address will not be published. Required fields are marked *